AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Retained-Earnings" stands at 8.21 Billion United States Dollars as of 09/30/2025, the highest value since 03/31/2018.
As of the end of AstraZeneca PLC's third quarter, the item "Retained Earnings" stands at 8.21 Billion USD. This represents an increase of 16.94 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.08 Billion United States Dollars compared to the value the year prior.
The 1 year change is 5.08 Billion United States Dollars.
The 3 year change is 10.68 Billion United States Dollars.
The 5 year change is 6.34 Billion United States Dollars.
The 10 year change is -2.49 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Retained Earnings | 486,508,953,600.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | Novartis AG - Retained Earnings | 255,096,620,580.91 |